BIMI International Medical Inc. Common Stock
BIMI
BIMI was delisted on the 21st of August, 2024.
4 hedge funds and large institutions have $28.7K invested in BIMI International Medical Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
28% less capital invested
Capital invested by funds: $40K → $28.7K (-$11.3K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$2.69K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$4.49K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$2.39K |
BIMI Hedge Fund Activity: Q3 2017 in Review
4 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in BIMI International Medical Inc. Common Stock (BIMI) for Q3 2017, worth a combined $28.7K — down 28% from $40K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BIMI positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was UBS Group, adding an estimated $2.69K. The largest seller was Citadel Advisors, cutting an estimated $4.49K.
- 4 institutional investors held BIMI International Medical Inc. Common Stock (BIMI) as of Q3 2017, unchanged from Q2 2017.
- Funds reported $28.7K of BIMI International Medical Inc. Common Stock stock for Q3 2017, down 28% quarter-over-quarter.
- 1 fund opened new BIMI International Medical Inc. Common Stock positions in Q3 2017 and 0 closed out, a net change of +1 holder.
- The largest BIMI International Medical Inc. Common Stock buyer in Q3 2017 was UBS Group, an estimated $2.69K added.
- The largest BIMI International Medical Inc. Common Stock seller in Q3 2017 was Citadel Advisors, an estimated $4.49K sold.
Based on aggregated 13F filings for Q3 2017.